World's Best Scientists 2026 revealed!
Gregory R. Pond

Gregory R. Pond

D-Index & Metrics

Medicine

D-Index
88
Citations
26078
World Ranking
13246
National Ranking
545

Overview

Gregory R. Pond is affiliated with McMaster University in Canada. Their research primarily belongs to the field of Medicine, with a significant focus on Oncology, Pulmonary and Respiratory Medicine, Cancer Research, Surgery, and Radiology, Nuclear Medicine and Imaging.

The main topics of their work include Multiple Myeloma Research and Treatments, Breast Cancer Treatment Studies, Cancer Immunotherapy and Biomarkers, Cancer Treatment and Pharmacology, Prostate Cancer Treatment and Research, Lung Cancer Diagnosis and Treatment, and Bladder and Urothelial Cancer Treatments.

Recent publications by Gregory R. Pond cover a range of topics and include the following papers:

  • Comparison of Multiparametric Magnetic Resonance Imaging-Targeted Biopsy With Systematic Transrectal Ultrasonography Biopsy for Biopsy-Naive Men at Risk for Prostate Cancer (2021, JAMA Oncology)
  • Omitting Radiotherapy after Breast-Conserving Surgery in Luminal A Breast Cancer (2023, New England Journal of Medicine)
  • Developing a Data and Analytics Platform to Enable a Breast Cancer Learning Health System at a Regional Cancer Center (2023, JCO Clinical Cancer Informatics)
  • Metformin in Combination With Chemoradiotherapy in Locally Advanced Non-Small Cell Lung Cancer (2021, JAMA Oncology)
  • Five-Factor Prognostic Model for Survival of Post-Platinum Patients with Metastatic Urothelial Carcinoma Receiving PD-L1 Inhibitors (2020, The Journal of Urology)

Frequent coauthors working with Gregory R. Pond include:

  • Lisa Vandermeer
  • Hsien Seow
  • Hira Mian
  • John Hilton
  • Mark Clemons

In terms of publication venues, this scientist commonly publishes in:

  • Journal of Clinical Oncology
  • Current Oncology
  • Cancer Research
  • Blood
  • Gynecologic Oncology

Best Publications

  • Frequency of infection in patients with rheumatoid arthritis compared with controls: a population-based study.

    Michele F. Doran;Cynthia S. Crowson;Gregory R. Pond;W. Michael O'Fallon

  • Docetaxel Plus Prednisone or Mitoxantrone Plus Prednisone for Advanced Prostate Cancer: Updated Survival in the TAX 327 Study

    Dominik R. Berthold;Gregory R. Pond;Freidele Soban;Ronald de Wit

  • Predictors of infection in rheumatoid arthritis

    Michele F. Doran;Cynthia S. Crowson;Gregory R. Pond;W. Michael O'Fallon

  • Trends in incidence and mortality in rheumatoid arthritis in Rochester, Minnesota, over a forty‐year period

    Michele F. Doran;Gregory R. Pond;Cynthia S. Crowson;W. Michael O'Fallon

  • Measured and estimated GFR in healthy potential kidney donors.

    Andrew D Rule;Hiie M Gussak;Gregory R Pond;Erik J Bergstralh

  • Medication Reconciliation at Hospital Discharge: Evaluating Discrepancies

    Jacqueline D Wong;Jana M Bajcar;Gary G Wong;Shabbir M H Alibhai

  • Combining Gemcitabine and Capecitabine in Patients With Advanced Biliary Cancer: A Phase II Trial

    Jennifer J. Knox;David Hedley;Amit Oza;Ron Feld

  • A phase II clinical and pharmacodynamic study of temsirolimus in advanced neuroendocrine carcinomas.

    Duran I;Kortmansky J;Singh D;Hirte H

  • Evaluating Survivorship Care Plans: Results of a Randomized, Clinical Trial of Patients With Breast Cancer

    Eva Grunfeld;Jim A. Julian;Gregory Pond;Elizabeth Maunsell

  • Direct medical costs attributable to osteoporotic fractures.

    S. E. Gabriel;A. N. A. Tosteson;C. L. Leibson;C. S. Crowson

  • Phase II Study of Lapatinib in Recurrent or Metastatic Epidermal Growth Factor Receptor and/or erbB2 Expressing Adenoid Cystic Carcinoma and Non–Adenoid Cystic Carcinoma Malignant Tumors of the Salivary Glands

    Mark Agulnik;Ezra W.E. Cohen;Roger B. Cohen;Eric X. Chen

  • Metformin inhibits growth and enhances radiation response of non-small cell lung cancer (NSCLC) through ATM and AMPK

    Storozhuk Y;Hopmans Sn;Sanli T;Sanli T;Barron C

  • Phase II Trial of Sorafenib in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck or Nasopharyngeal Carcinoma

    Christine Elser;Lillian L. Siu;Eric Winquist;Mark Agulnik

  • Imatinib Mesylate in Patients With Adenoid Cystic Cancers of the Salivary Glands Expressing c-kit: A Princess Margaret Hospital Phase II Consortium Study

    Sébastien J. Hotte;Eric W. Winquist;Elizabeth Lamont;Mary MacKenzie

  • Treatment of Hormone-Refractory Prostate Cancer with Docetaxel or Mitoxantrone: Relationships between Prostate-Specific Antigen, Pain, and Quality of Life Response and Survival in the TAX-327 Study

    Dominik R. Berthold;Gregory R. Pond;Martin Roessner;Ronald de Wit

  • Side effects associated with the use of dexamethasone for prophylaxis of delayed emesis after moderately emetogenic chemotherapy.

    J Vardy;K S Chiew;J Galica;G R Pond

  • The Position of the Polycystic Kidney Disease 1 (PKD1) Gene Mutation Correlates with the Severity of Renal Disease

    Sandro Rossetti;Sarah Burton;Lana Strmecki;Gregory R. Pond

  • Cognitive Function in Patients With Colorectal Cancer Who Do and Do Not Receive Chemotherapy: A Prospective, Longitudinal, Controlled Study

    Janette L. Vardy;Haryana M. Dhillon;Gregory R. Pond;Sean B. Rourke

  • Phase II study of erlotinib (OSI-774) in patients with metastatic colorectal cancer

    C A Townsley;P Major;L L Siu;J Dancey

  • Pharmacist medication assessments in a surgical preadmission clinic.

    Yvonne Kwan;Olavo A. Fernandes;Jeff J. Nagge;Gary G. Wong

Frequent Co-Authors

Lillian L. Siu
Lillian L. Siu University of Toronto
Joaquim Bellmunt
Joaquim Bellmunt Beth Israel Deaconess Medical Center
Toni K. Choueiri
Toni K. Choueiri Harvard University
Mark Levine
Mark Levine McMaster University
Ian F. Tannock
Ian F. Tannock University of Toronto
Amit M. Oza
Amit M. Oza Princess Margaret Cancer Centre
Jonathan E. Rosenberg
Jonathan E. Rosenberg Memorial Sloan Kettering Cancer Center
Andrew J. Armstrong
Andrew J. Armstrong Duke University
Dean F. Bajorin
Dean F. Bajorin Memorial Sloan Kettering Cancer Center
Kathleen I. Pritchard
Kathleen I. Pritchard University of Toronto

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a future in Medicine doesn't always mean attending a traditional medical school. Many professionals choose alternative health-related degrees that can be completed fully or partly online, offering flexible options for different career paths in healthcare.

Nursing is a popular route, with programs that accommodate various levels of experience. For advanced practice, the easiest dnp program online pathways allow registered nurses to achieve a Doctor of Nursing Practice efficiently. Those looking to start working quickly may consider an accelerated lpn program, offering a swift route into the nursing field.

Specializing further, psychiatric care is in growing demand. For those interested in mental health, psych nurse practitioner programs online provide focused, fast-tracked graduate education for aspiring psychiatric nurse practitioners.

Not all healthcare leaders work in clinical roles. If you're interested in shaping healthcare policy or managing organizations, pursuing a health administration degree online opens doors to administrative positions across hospitals, clinics, and public health agencies.

Best Scientists Citing Gregory R. Pond

Trending Scientists